Related Experiment Video
Updated: Nov 6, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Treatments of Sexual Dysfunction in Opioid Substitution Therapy Patients: A Systematic Review and Meta-Analysis
Fitri Fareez Ramli1, Muhammad Hasif Azizi2, Syed Alhafiz Syed Hashim1
1Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000 Cheras, Kuala Lumpur, Malaysia.
Abstract:
Sexual dysfunction is a common condition in the opioid substitution therapy (OST) population. We aimed to determine the efficacy and safety of treatment for sexual dysfunction in the OST population. We searched for interventional studies from Medline, PubMed, and Scopus. Three independent authors conducted a risk-of-bias assessment (RoB 2). A total of seven studies (five randomized-controlled trials, two quasi-experimental), including 473 patients with sexual dysfunction, were identified. Among these, three bupropion (n=207), one trazodone (n=75), two rosa Damascena (n=100), and one ginseng (n=91) studies had reported significantly improve various sexual functioning domains in both genders. In a meta-analysis, bupropion significantly increased male sexual function with standardized mean difference of 0.53; 95% confidence interval of 0.19-0.88; P < 0.01; I2=0. The adverse effects were minor for all agents, and no significant difference between treatment and placebo groups in randomized-controlled trials. These agents have a promising future as therapy for sexual dysfunction in the OST population. However, given the limited sample size and number of studies, further studies should be conducted to confirm the use of these agents.
Insights
Treatments like bupropion, trazodone, Rosa Damascena, and ginseng show promise for improving sexual dysfunction in patients undergoing opioid substitution therapy (OST). Adverse effects were minimal, suggesting a safe therapeutic option for this population.
Area of Science:
- Pharmacology
- Sexual Health
- Addiction Medicine
Background:
- Sexual dysfunction is prevalent among individuals receiving opioid substitution therapy (OST).
- Addressing sexual dysfunction is crucial for improving the overall well-being and treatment adherence in the OST population.
Purpose of the Study:
- To evaluate the efficacy and safety of various treatments for sexual dysfunction in patients undergoing OST.
- To synthesize evidence from interventional studies on pharmacological and herbal interventions.
Main Methods:
- Systematic literature search of Medline, PubMed, and Scopus for interventional studies.
- Inclusion of five randomized-controlled trials and two quasi-experimental studies.
- Risk-of-bias assessment using RoB 2 by three independent authors.
- Meta-analysis conducted for bupropion's effect on male sexual function.
Main Results:
- Seven studies involving 473 patients were identified, examining bupropion, trazodone, Rosa Damascena, and ginseng.
- Bupropion, trazodone, Rosa Damascena, and ginseng demonstrated significant improvements in various sexual functioning domains for both genders.
- Meta-analysis confirmed bupropion significantly enhanced male sexual function (SMD = 0.53, P < 0.01).
- All treatments exhibited minor adverse effects with no significant differences compared to placebo in RCTs.
Conclusions:
- Bupropion, trazodone, Rosa Damascena, and ginseng are promising therapeutic options for sexual dysfunction in the OST population.
- These agents appear safe with minimal adverse effects.
- Further research with larger sample sizes is warranted to confirm these findings and guide clinical practice.
More Related Videos
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Receptors: Overview
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Antidepressant Drugs: MAOIs and Other Agents

